Meloxicam Gp

Meloxicam, the active ingredient in Meloxicam Gp, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for systemic use. It is used to relieve pain and inflammation associated with osteoarthritis, rheumatoid arthritis and other musculoskeletal conditions in adult patients.

GNH USA supplies Meloxicam Gp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for cross‑border distribution. Clients benefit from reliable logistics, batch traceability and responsive technical support throughout the supply chain.

Meloxicam is indicated for inflammatory and degenerative joint disorders where cyclo‑oxygenase inhibition reduces pain and swelling.

Osteoarthritis: alleviates joint pain and improves mobility in patients with degenerative cartilage loss. Rheumatoid arthritis: decreases synovial inflammation and joint damage progression in autoimmune arthritis. Musculoskeletal pain: provides analgesic relief for acute or chronic soft‑tissue injuries and strain.

Meloxicam may cause a range of adverse reactions, from mild and frequent to rare but serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, abdominal pain, or mild heartburn. - Headache: mild to moderate intensity, often transient. - Dizziness or vertigo: sensation of light‑headedness, especially on standing.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: potentially life‑threatening hemorrhage. - Hepatotoxicity: elevated liver enzymes, hepatitis, or jaundice. - Renal impairment: acute kidney injury or worsening of chronic kidney disease. - Severe hypersensitivity reactions: Stevens‑Johnson syndrome, toxic epidermal necrolysis, or anaphylaxis.

Before prescribing meloxicam, clinicians should evaluate patient‑specific risk factors and monitor for adverse events. - Assess renal and hepatic function before initiating therapy. - Use lowest effective dose for shortest duration to limit gastrointestinal risk. - Avoid concomitant use with other NSAIDs, anticoagulants, or corticosteroids unless medically justified. - Monitor for signs of cardiovascular events, especially in patients with existing heart disease. - Counsel patients on recognizing symptoms of ulceration, bleeding, or severe skin reactions. - Store at ambient temperature below 25°C: keep in original container, protect from moisture and direct sunlight.

Meloxicam can interact with several drug classes, requiring careful assessment of benefit versus risk.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Selective COX‑2 inhibitors (e.g., celecoxib): additive toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion, monitor kidney function. - Diuretics: potential for reduced efficacy and electrolyte imbalance. - Lithium: NSAIDs can increase lithium levels, require serum monitoring.